Nuclear Fuels Commences 2025 Kaycee Uranium Project Drill Program
CSE:NF
OTCQX:NFUNF
Highlights from the 2024 Regional Exploration Program (Nuclear Fuels NR
- Drill hole LT24_050 returned 0.082% eU3O8 over 6.5 feet for a total grade thickness ("GT") of 0.532, beginning at a downhole depth of 767.0 feet at the
Outpost Zone ; - At the
Trail Dust Zone , located approximately 1.5 miles to the north of theOutpost Zone , drill hole LT24_037 returned 0.0553% eU3O8 over 5.5 feet for a total hole GT of 0.304, beginning at a downhole depth of 886.0 feet; - The 2025 exploration program is now underway at the Project and will follow up on these results, as well as test other high priority targets;
- This fully-funded exploration program consists of an initial 100,000 feet of rotary mud drilling, with results to be reported at a similar cadence to the 2024 drill program.
"Our 2025 drill program is designed to build on the discovery of the
Strategic Transaction with Premier American Uranium Inc.
On
Kaycee Uranium Project,
The Kaycee Project in
In 2023, Nuclear Fuels acquired the Kaycee Project from enCore Energy Corp., which retains a back-in right for 51% of the project by paying 2.5X the exploration costs and financing the Kaycee project to production (costs recoverable from production) upon Nuclear Fuels establishing a minimum 15 million pound eU3O8 43-101 compliant resource.
The technical content of this news release has been reviewed and approved by
About Nuclear Fuels Inc.
Nuclear Fuels Inc. is a uranium exploration company advancing early-stage, district-scale In-Situ Recovery ("ISR") amenable uranium projects towards production in
Forward-Looking Information
The Canadian Securities Exchange has not reviewed this press release and does not accept responsibility for the adequacy or accuracy of this news release.
Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements relating to planned exploration programs and the results of additional exploration work in seeking to establish mineral resources as defined in NI43-101 on any of our properties. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with the completing planned exploration programs and the results of those programs; the ability to access additional capital to fund planned and future operations; regulatory risks including exploration permitting; risks associated with title to our mineral projects; the ability of the company to implement its business strategies; and other risks including risks contained in documents available for review at www.sedar.com under the Company's profile. Readers are cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuclear-fuels-commences-2025-kaycee-uranium-project-drill-program-302478347.html
SOURCE Nuclear Fuels Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GOOD WORKS, GIVING, AND GLAMOUR SHINE AT NORTH SHORE ANIMAL LEAGUE AMERICA'S RESCUE GALA CELEBRATING ANIMAL RESCUE AND ADOPTION
- Masters Garage Door Services Provides 24/7 Garage Door Repair and Installation in Beaumont
- Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share